Matthew L. Brown

发表

Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors.

P. A. Harris, J. Veal, Liping Wang, 2005, Journal of medicinal chemistry.

Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists.

R. Hungate, M. Rong, W. Zhong, 2010, Bioorganic & medicinal chemistry letters.

Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hit.

R. Hungate, M. Rong, W. Zhong, 2011, Bioorganic & medicinal chemistry letters.

Expanding uranyl dicyanoaurate coordination polymers into the second and third dimensions

Matthew L. Brown, D. Leznoff, 2020, Canadian Journal of Chemistry.

Photo- and thermal-induced multistructural transformation of 2-phenylazolyl chelate boron compounds.

N. Mosey, Yingli Rao, Suning Wang, 2013, Journal of the American Chemical Society.

Rapid interconversion of diastereomers of [PdCl{P(OC6H4NMe)2}{P(OC6H4NMe)OC6H4NHMe}]

Matthew L. Brown, C. Montgomery, Hannah K. Carroll, 2020 .

Synthesis and electronic structure determination of uranium(vi) ligand radical complexes.

T. Storr, Matthew L. Brown, B. Patrick, 2016, Dalton transactions.

Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.

G. Durst, C. Montrose‐Rafizadeh, L. Stramm, 2015, Bioorganic & medicinal chemistry letters.

Mixed‐Donor Amido–Siloxo Actinide(IV) Halide and Alkyl Complexes with an Aryl Cipso Interaction

Matthew L. Brown, D. Leznoff, C. Hayes, 2014 .

3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists.

P. Jadhav, Matthew L. Brown, T. Grese, 2005, Bioorganic & medicinal chemistry letters.

Dicyanoaurate-based heterobimetallic uranyl coordination polymers.

Matthew L. Brown, Jeffrey S. Ovens, D. Leznoff, 2017, Dalton transactions.

Enantioselective reductive amination of α-keto acids to α-amino acids by a pyridoxamine cofactor in a protein cavity

M. Distefano, Matthew L. Brown, H. Kuang, 1996 .

Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability

K. Rex, A. Coxon, N. Walker, 2013, PloS one.

Structure guided design of a series of sphingosine kinase (SphK) inhibitors.

Holger Wesche, Frank Kayser, Alan C Cheng, 2013, Bioorganic & medicinal chemistry letters.

Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1.

Matthew L. Brown, R. McCarley, Bijeta Prasai, 2013, Journal of the American Chemical Society.

Emissive lanthanide dicyanoaurate coordination polymers with 2,2′-bipyridine dioxide antenna groups and their hydration states

Matthew L. Brown, D. Leznoff, Thomas E. Karpiuk, 2023, CrystEngComm.

Photo- and thermal-induced multistructural transformation of 2-phenylazolyl chelate boron compounds.

N. Mosey, Yingli Rao, Suning Wang, 2013, Journal of the American Chemical Society.

Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hit.

R. Hungate, M. Rong, W. Zhong, 2011, Bioorganic & medicinal chemistry letters.